1. Wu, C, Wen, Y, Guo, X, Deng, H-W, Zhang, F. 2016. Genetic association, mRNA and protein expression analysis identify ATG4C as a susceptibility gene for Kashin-Beck disease. In Osteoarthritis and cartilage, 25, 281-286. doi:10.1016/j.joca.2016.09.019. https://pubmed.ncbi.nlm.nih.gov/27742532/
2. Sazonovs, Aleksejs, Stevens, Christine R, Venkataraman, Guhan R, Anderson, Carl A, Daly, Mark J. 2022. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility. In Nature genetics, 54, 1275-1283. doi:10.1038/s41588-022-01156-2. https://pubmed.ncbi.nlm.nih.gov/36038634/
3. Wen, Zhi-Peng, Zeng, Wen-Jing, Chen, Yan-Hong, Xiao, Jian, Chen, Xiao-Ping. 2019. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. In Journal of experimental & clinical cancer research : CR, 38, 298. doi:10.1186/s13046-019-1287-8. https://pubmed.ncbi.nlm.nih.gov/31291988/
4. Zeng, Yuyang, Chen, Mengxi, Ganesh, Sridha, Hu, Shunze, Chen, Honglei. 2020. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer. In PloS one, 15, e0232235. doi:10.1371/journal.pone.0232235. https://pubmed.ncbi.nlm.nih.gov/32401768/